Acelrx Pharmaceuticals IncのEV/Sales
Acelrx Pharmaceuticals IncのEV/Salesは何ですか。
Acelrx Pharmaceuticals IncのEV/Salesは8.22です。
EV/Salesの定義は何ですか。
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
NASDAQのセクタHealth CareにおけるEV/Salesの企業と比べるAcelrx Pharmaceuticals Inc
Acelrx Pharmaceuticals Incは何をしますか。
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Acelrx Pharmaceuticals Incと類似のev/sales
- Arista Networks IncのEV/Salesは8.20です。
- AmericannのEV/Salesは8.21です。
- PCSB CorpのEV/Salesは8.21です。
- NeuroOne Medical TechnologiesのEV/Salesは8.21です。
- Edenred SAのEV/Salesは8.21です。
- Collagen Solutions plcのEV/Salesは8.22です。
- Acelrx Pharmaceuticals IncのEV/Salesは8.22です。
- Coho Collective KitchensのEV/Salesは8.22です。
- Smart Metering Systems PlcのEV/Salesは8.23です。
- LM Funding America IncのEV/Salesは8.23です。
- Cousins PropertiesのEV/Salesは8.23です。
- Vertex PharmaceuticalsのEV/Salesは8.23です。
- NanoXploreのEV/Salesは8.23です。